Literature DB >> 594663

Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.

M Björkholm, G Holm, H Mellstedt, B Johansson, J Askergren, G Söderberg.   

Abstract

An unselected material of 83 consecutive and previously untreated adult patients with Hodgkin's disease (HD) from the Stockholm area is presented. The distribution of patients according to age was characteristically bimodal. The histopathological subtypes were 16% lymphocyte predominance (LP), 33% nodular sclerosis (NS), 37% mixed cellularity (MC) and 11% lymphocyte depletion (LD). The patients were treated with aggressive megavoltage irradiation and multidrug chemotherapy. Major factors affecting prognosis were age, clinical stage and constitutional symptoms. Patients with LP and NS subtypes had only slightly better prognosis that patients classified as MC and LD. The overall survival was 68% at 41/2 years, which is close to that reported from other groups with similar composition of their materials with regard to age, histopathology and stage.

Entities:  

Mesh:

Year:  1977        PMID: 594663

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  6 in total

1.  Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease.

Authors:  O Landgren; U Axdorph; H Jacobsson; B Johansson; G Grimfors; M Björkholm
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

2.  Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age.

Authors:  C Wedelin; M Björkholm; B Johansson; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Individual quality of life in long-term survivors of Hodgkin's lymphoma--a comparative study.

Authors:  L Wettergren; M Björkholm; U Axdorph; A Bowling; A Langius-Eklöf
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

4.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

5.  Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.

Authors:  J Askergren; M Björkholm; G Holm; B Johansson; H Mellstedt; R Sundblad; G Söderberg
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

6.  Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.

Authors:  U Axdorph; A Porwit-MacDonald; J Sjöberg; G Grimfors; M Ekman; W Wang; P Biberfeld; M Björkholm
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.